Salbutamol 4 mg WFZ

Description

Salbutamol 4 mg WFZ — Backed by a rigorous commitment to quality, this pharmaceutical-grade thermogenic compound accelerates fat metabolism and supports lean body composition during cutting phases. Enhances metabolic rate while preserving lean muscle tissue. This formulation is dosed at 4 mg per unit.

Key Benefits

• β2-agonist — standard asthma bronchodilator
• Modest thermogenic and fat-mobilising effects
• Milder than clenbuterol; shorter half-life
• Oral or inhaled; performance use typically oral
• 2-on / 2-off cycling recommended like clenbuterol
• Each unit dosed at 4 mg — see Recommended Dosage below for protocol-specific intake

How It Works

Selective β2-adrenergic agonist. Bronchodilation primary effect; metabolic effects (increased cAMP → lipolysis) secondary. Milder thermogenic profile than clenbuterol due to shorter half-life.

Pharmacokinetics

Plasma half-life approximately 4–6 hours. Multiple daily doses required for continuous effect. Oral bioavailability ~50%.

Potential Side Effects

Tremors, tachycardia, headache, muscle cramps (taurine supplementation helps). Tolerance develops — hence 2-on / 2-off cycling. Cardiac hypertrophy concern on long runs.

Cycle & Stacking Guide

Cutting-phase compound, 2-on / 2-off cycling. Milder alternative to clenbuterol. Avoid late-day dosing (insomnia).

Manufacturer Notes

WFZ is an independent producer in the research-compound market. Before first use, request the batch-specific Certificate of Analysis and confirm the vial’s tamper-evident seal is intact.

Storage & Handling

Store at recommended temperature (15–25°C; peptides and HGH at 2–8°C after reconstitution). Protect from light and moisture. Keep out of reach of children. For research and educational purposes only.